Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Synthomer has reported an 11.5% fall in its underlying operating profit in 2019, in spite of seeing a record return on R&D investment during the period.
Sales volumes were up 22% over the year, from new products launched in the past five years.
However, Ebitda was 1.7% lower at £177.9m in 2019, hit mainly by the performance of Elastomers SBR markets, the company said.
Underlying earnings per share is 25.3p, while the dividend per share is 10.9p.